In a recent decision, the US District Court of South Carolina reinforces the original intention of patient definition for 340B covered entities, advocating for a ‘broad’ interpretation. Emphasizing the program’s core mission, the ruling reinforces Congress’ initial intent—to safeguard vulnerable communities from skyrocketing drug costs. This reaffirmation solidifies the program’s commitment to ensuring vital access…

A New Groundbreaking Study Reveals Real-Life Impact, Cost Savings, and Barriers Faced by Underserved Diabetes Patients in Safety-Net Clinics   The federal 340B Drug Pricing Program provides discounted drug prices to safety-net entities, enabling them to serve more vulnerable patients. This program has become indispensable with the escalating costs of medications, including high-cost injectable diabetes…

Five Horizons Health Services Provides HIV Prevention in West Alabama & East Mississippi with 340B The 340B Program allows the rural healthcare facility to provide high-quality, patient-centered medical, dental, prevention, behavioral health, testing, and case management services. by Shey Thorn, MPH, Chief of Staff, Five Horizons Health Services October 2023   Five Horizons Health Services…

History of the 340B Program by Januari Fox, Director of Policy & Advocacy, Community Engagement, Prism Health North Texas Administration October 2022 Republished from the Dallas Medical Journal. Find the original article here.   A little-known program that establishes pathways of care for underserved communities is under attack by drug manufacturers. Created in 1992, the…